NMD Pharma
nmdpharma.com
Actively hiring
Rare Disease Therapeutics
Drug Discovery
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
51-200
employees, estimated range
Backers
2
Inkef, Jeito Capital
Momentum
0/100
no fresh signals
Registers and programsofficial lists and records that name the company
| Legal entity | NMD PHARMA A/S | its site |
Backed byfrom the funds' portfolios and accelerator catalogs
Inkef 
Jeito Capital Similar startupsby what they do, their industry and backers
Draupnir Bio is developing new innovative therapies for patients.
US FDA Grants Orphan Drug and Rare Pediatric Disease Designations to GEn1E Lifesciences' Dual Signal Modulator for the Treatment of…
About Us NephroDI Therapeutics is developing a novel AMPK activator as a first-in-class potential therapy for Nephrogenic Diabetes…
Mendra is a venture-backed rare-disease biopharma accelerating the development and commercialization of de-risked breakthrough therapies.
What We Do We are focused on creating precision radiopharmaceutical therapies (RPTs) that transform people’s lives.
Audion Therapeutics is a clinical-stage company dedicated to the development of therapies to treat Hearing Loss About Audion Hearing Loss…